The Scientist

» drug development, ecology and evolution

Most Recent

image: Image of the Day: Saltwater Survivors

Image of the Day: Saltwater Survivors

By | January 9, 2017

When road deicing salt enters freshwater ecosystems, prey species such as Daphnia pulex can rapidly evolve tolerance to the contaminant, buffering their local food webs from the impacts of salination.

1 Comment

image: Adaptation, Island Style

Adaptation, Island Style

By | January 3, 2017

Anole lizards inhabiting the Caribbean islands display some of the key principles of evolution.

0 Comments

The small lizards adapted to unique niches among dozens of isles.

1 Comment

image: Historical Hunts

Historical Hunts

By | January 1, 2017

See images from a century of fur trapping and hunting in the Amazon basin.

0 Comments

image: How an Invasive Bee Managed to Thrive in Australia

How an Invasive Bee Managed to Thrive in Australia

By | January 1, 2017

The Asian honeybee should have been crippled by low genetic diversity, but thanks to natural selection it thrived.

1 Comment

The public may still believe that male-specific traits, such as high testosterone levels, lead to many of the gender inequalities that exist in society, but science tells a different story.

2 Comments

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

Researchers use a century of trade records to uncover differences in the resilience of terrestrial and aquatic species.

0 Comments

image: Repurposing Existing Drugs for New Indications

Repurposing Existing Drugs for New Indications

By | January 1, 2017

An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.

1 Comment

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS